e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 10

Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and Proposal

Robin Murray; Alice Egerton; Yueming Gao; Anthony A. Grace; Oliver Howes; Sameer Jauhar; Stefan Leucht; Eric Chen · 2025 · Biological Psychiatry

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Much is known about the use, benefits, and side-effects, of clozapine in treatment resistant schizophrenia (TRS). However, why clozapine is more effective than other antipsychotics in TRS remains unclear. This paper addresses this question. TRS patients show glutamate abnormalities, and clozapine has widespread effects on glutamate. However, these actions have not been proven different to those of other antipsychotics. Immune dysfunction is also reported in TRS, and clozapine has anti-inflammatory actions, but these have not been correlated with clinical improvement. Currently, there is much i

Abstract by Robin Murray; Alice Egerton; Yueming Gao; Anthony A. Grace; Oliver Howes; Sameer Jauhar; Stefan Leucht; Eric Chen, Biological Psychiatry (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1016/j.biopsych.2025.06.011